Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolin

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3061-3069

  Qiu, Jin Feng ^a   Gao, Xiang ^a,b   Wang, Bi Lan ^a   Wei, Xia Wei ^a   Gou, Ma Ling ^a   Men, Ke ^a   Liu, Xing Yu ^a   Guo, Gang ^a   Qian, Zhi Yong ^a   Huang, Mei Juan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cancer therapy; Luteolin; Micelle; MPEG PCL

Indexed keywords

COPOLYMER; DRUG CARRIER; LUTEOLIN; MACROGOL; MONOMETHOXY POLY(ETHYLENE GLYCOL) POLY(EPSILON CAPROLACTONE) COPOLYMER; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CELL; CHEMICAL PARAMETERS; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; DRUG SOLUBILITY; ENCAPSULATION; IN VIVO STUDY; MICELLE; NONHUMAN; PARTICLE SIZE; POLYDISPERSITY INDEX; RAT; SLOW RELEASE FORMULATION;

CANCER THERAPY; LUTEOLIN; MICELLE; MPEG-PCL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; LUTEOLIN; MICE; MICELLES; NANOPARTICLES; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84881567777     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S45062     Document Type: Article

References (33)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70(3):461-477.
3. Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem. 2008;51(9): 2589-2599.
4. Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13(19-20):894-901.
5. Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55(6):481-504.
6. Lin Y, Shi R, Wang X, Shen HM. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8(7): 634-646.
7. Seelinger G, Merfort I, Wölfle U, Schempp CM. Anti-carcinogenic effects of the flavonoid luteolin. Molecules. 2008;13(10):2628-2651.
8. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. Flavonoids: a review of probable mechanisms of action and potential applications. The Am J Clin Nutr. 2001;74(4): 418-425.
9. Ueda H, Yamazaki C, Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull. 2002;25(9):1197-1202.
10. Attoub S, Hassan AH, Vanhoecke B, et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol. 2011;651(1-3):18-25.
11. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS. Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res. 2008;87(4): 401-406.
12. Horinaka M, Yoshida T, Shiraishi T, et al. Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene. 2005;24(48):7180-7189.
13. Byun S, Lee KW, Jung S., et al. Luteolin inhibits protein kinase Cε and c-Src activities and UVB-induced skin cancer. Cancer Res. 2010;70(6): 2415-2423.
14. Jang S, Kelley KW, Johnson RW. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A. 2008;105(21):7534-7539.
15. Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther. 2009;8(6):1684-1691.
16. Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact. 2006;160(2):123-133.
17. Bagli E, Stefaniotou M, Morbidelli L, et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res. 2004;64(21):7936-7946.
18. Samy RP, Gopalakrishnakone P, Ignacimuthu S. Anti-tumor promoting potential of luteolin against 7, 12-dimethylbenz(a)anthraceneinduced mammary tumors in rats. Chem Biol Interact. 2006;164(1-2): 1-14.
19. Kaminaga Y, Nagatsu A, Akiyama T, et al. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. FEBS Lett. 2003;555(2): 311-316.
20. Zhou P, Li LP, Luo SQ, Jiang HD, Zeng S. Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin. J Agric Food Chem. 2008;56(1):296-300.
21. Chen Z, Tu M, Sun S, et al. The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats. Drug Metab Pharmacokinet. 2012;27(1):162-168.
22. Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008;2(8): 1696-1702.
23. Gou ML, Wei XW, Men K, et al. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets. 2011;12(8):1131-1150.
24. Gou ML, Men K, Shi HS, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3(4):1558-1567.
25. Wei XW, Gong CY, Gou ML, et al. Biodegradable poly(ε-caprolactone)- poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm. 2009;381(1):1-18.
26. Gou ML, Zheng XL, Men K, et al. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm Res. 2009;26(9):2164-2173.
27. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1): 1-18.
28. Turner M, Clough G, Michel C. The effects of cationised ferritin and native ferritin upon the filtration coefficient of single frog capillaries. Evidence that proteins in the endothelial cell coat influence permeability. Microvasc Res. 1983;25(2):205-222.
29. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79(3):581-589.
30. Dellian M, Yuan F, Trubetskoy V, Torchilin V, Jain R. Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer. 2000;82(9):1513-1518.
31. Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics. 2011;3(4):793-829.
32. Kwon Y, Kim H, Park S, Jung S. Enhancement of solubility and antioxidant activity of some flavonoids based on the inclusion complexation with sulfobutylether β-cyclodextrin. Bull Korean Chem Soc. 2010;31(10):3035-3037.
33. Kim H, Jung S. Aqueous solubility enhancement of some flavones by complexation with cyclodextrins. Bull Korean Chem Soc. 2008;29(3): 590-594.